Rapid Diagnostics Market - Trends Forecast Till 2028

Rapid Diagnostics Market by Product (Glucose, Infectious Disease (Hepatitis C, Influenza), Coagulation), Platform (Microfluidics, Immunoassay), Mode of Purchase (Prescription, OTC), Enduser (Hospital, e-comm, Home Care), and Region (North America, Europe, Asia-Pacific, Middle East and Africa and South America)

Published Date: January, 2022

Base Year Estimate: 2021

Report ID: D-HC-RDM-1116

Format:  

Number of Pages: 377

Domain: Healthcare

Rapid Diagnostics Market – Trends Forecast Till 2028

The Rapid Diagnostics market size is projected to reach a CAGR of 11.6% from 2022 to 2028.

Rapid Diagnostics are the medical techniques which are used for the diagnosis and the detection of the disease but are way to perform and are quick. These techniques play major role in the situation wherein the preliminary or the emergency situation similar to the ongoing pandemic. These test kits tend to provide the results in either 20 minutes or the same day.

The technological advancements in the sector along with the surge in the incidents of the infectious disease are some of the factors that have supported long-term expansion for Rapid Diagnostics Market.

COVID-19 had a positive effect on the market, as because the global demand has increased to various folds and also the shortage of lab-based testing facilities the demand for rapid diagnostics was increased.

Rapid Diagnostics Market Growth Forecast

North America is the most rapidly growing market and offers a huge opportunity for the industry, whose growth is driven by the incidents of lifestyle disorder becoming popular in the region and also the presence of the key players in the region.

Rapid Diagnostics Market is segmented into product, platform, mode of purchase, end users and region.

On the basis of Product

  • Glucose Monitoring Products
  • Cardiometabolic Monitoring Products
  • Infectious Disease Testing Products
  • Coagulation Monitoring Products
  • Pregnancy & Fertility Testing Products
  • Fecal Occult Testing Products
  • Hematology Testing Products
  • Tumor/Cancer Marker Testing Products
  • Urinalysis Testing Products
  • Drugs-of-abuse Testing Products
  • Cholesterol Testing Products
  • Other POC Products

On the basis of Purchase

  • OTC Testing Products
  • Prescription-based Testing Products

On the basis of End-Users

  • Outpatient & Ambulatory Care Facilities
  • Hospitals & Critical Care Centers
  • Home Care Settings 5
  • Other End Users

On the basis of Region

  • Asia Pacific
  • North America
  • Europe
  • South America
  • Middle East & Africa

Insights are provided for each region and major countries within the regions

Rapid Diagnostics Market Primary Respondent

 

Key Players

  • Roche Diagnostics
  • Siemens Healthineers
  • Danaher Corporation
  • Becton Dickinson and Company
  • Abbott Laboratories
  • Quidel Diagnostics
  • Chembio Diagnostics
  • EKF Diagnostics
  • Trinity Biotech
  • Fluxergy

Recent Developments

  • In June 2019, FDA gave the approval to Roche diagnostics for VENTANA PD-L1 (SP142) Assay.

Reasons to Acquire

  • Increase your understanding of the market for identifying the best and suitable strategies and decisions on the basis of sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends and factors
  • Gain authentic and granular data access for Rapid Diagnostics  Market so as to understand the trends and the factors involved behind changing market situations
  • Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future
  • In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns

Report Scope

 

Report Feature

Descriptions

Growth Rate

CAGR of 11.6% during the forecasting period, 2022-2028

Historical Data

2019-2020

Forecast Years

2022-2028

Base Year

2021

Units Considered

Revenue in USD billion and CAGR from 2022 to 2028

Report Segmentation

product, platform, mode of purchase, end users and region.

Report Attribute

Market Revenue Sizing (Global, Regional and Country Level) Company Share Analysis, Market Dynamics, Company Profiling

Regional Level Scope

North America, Europe, Asia-Pacific, South America, and Middle East and Africa

Country Level Scope

U.S., Japan, Germany, U.K., China, India, Brazil, UAE, South Africa (50+ Countries Across the Globe)

Companies Profiled

Roche Diagnostics , Siemens Healthineers , Danaher Corporation , Becton Dickinson and Company , Abbott Laboratories , Quidel Diagnostics , and Chembio Diagnostics EKF Diagnostics , Trinity Biotech , and Fluxergy

Available Customization

In addition to the market data for Rapid Diagnostics Market, Delvens offers client-centric report and customized according to the company’s specific demand and requirement.

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Choose License Type
Global: 50+ Countries

Note: Report data and information will be by Country.


Regional Report

Note: Report data and information will be by Country.


Country Specific Report

Bundle Reports

50% Discount on all additional reports  

Special Pricing

Avail customised purchase options to meet your specific research requirements.

Custom Tailored Services

Delvens. offers transformed research reports where syndicated reports are not sufficient to provide solutions to your business.

Subscription Model

Get latest and trending updates throughout the year on the reports you buy.